Scientific research in Luxembourg

Drug and drug-addition research provides valuable insights into a variety of problems associated with drug use. It also helps us to gain a better understanding of emerging trends in drug use, new ways in which drugs are consumed, and the health risks associated with and damage caused by drug use.

Here are just some recently published scientific articles on the situation in Luxembourg:

  • Arendt, V., Guillorit, L., Origer, A., Sauvageot, N., Vaillant, M., Fischer, A., et al. (2019). Injection of cocaine is associated with a recent HIV outbreak in people who inject drugs in Luxembourg. PLoSONE, 14(5):e0215570. https://doi.org/10.1371/journal.pone.0215570

  • Berndt, N., Paulos, C. & Seixas, R. (2021). Mini-European Web Survey on Drugs: Impact of COVID-19 on drug use, acquisition behaviour and the drug market in Luxembourg. Luxembourg: Health Directorate, Ministry of Health. https://sante.public.lu/fr/actualites/2021/04/enquete-drogues/report-mini-ewsd.pdf

  • Berndt, N., & Seixas, R. (2019). European Web Survey on Drugs: national implementation among a targeted sample of recreational drug users in Luxembourg 2018 [European Web Survey on Drugs in Luxembourg, 2018]. Luxembourg: EMCDDA Luxembourg Focal Point - EUDA Luxembourg Focal Point, Epidemiology and Statistics Dept. (Service épidémiologie et statistique), Health Directorate. https://sante.public.lu/en/publications/e/etat-drogue-europe-2019-factsheet-en/factsheet-eu-survey-drugs-2019.pdf

  • Berndt, N., Seixas, R. & Devaux, C. (2019). Combattre l'hépatite C chez les usagers de drogues injectables au Luxembourg: illustration d'une approche intersectorielle. Addictions : recherche et pratiques, 4, pp. 22-25.

  • Berndt, N., Seixas, R., Teyssier, E. & Origer, A. (2021). Étude de l‘impact de la COVID-19 sur les pratiques de consommation et l’utilisation des offres spécialisées par des usagers de drogues à haut-risque au Grand-Duché de Luxembourg. Luxembourg: Health Directorate, Ministry of Health. https://www.emcdda.europa.eu/system/files/attachments/13931/Rapport-UDHR-COVID19-PFLDT-version-finale.pdf

  • Bourmaud, A., Dahm, G., Meys, F., Gengler, N., Origer, A. & Schneider, S. (2021). Investigation on heroin and cocaine quality in Luxembourg. Harm Reduction Journal 18, 97. https://doi.org/10.1186/s12954-021-00544-x

  • Fischer, A., Etienne, V., Guillorit, L., Biwersi, G., Origer, A., Devaux, C., Staub, T., & Arendt, V. (2017). Epidemiology of HIV and cascade of care in 2016 in injecting drug users from 1983 to 2016 in Luxembourg. IAS 2017 • 9th IAS Conference on HIV Science, 23 - 26 July 2017, Paris, France. http://www.ias2017.org/Portals/1/Files/IAS2017_LO.compressed.pdf?ver=2017-07-27-211231-197

  • Foulon, M. (2020). Étude sur la consommation de drogues en prison au Grand-Duché de Luxembourg (Unpublished doctoral thesis). Faculty of Medicine, Université Paris Sud, Paris.

  • Heinz, A., Kern, M. R., Residori, C., Catunda, C., van Duin, C., & Willems, H. (2018). Cannabiskonsum von Schülern in Luxemburg. HBSC-Factsheets Luxemburg Nr. 7 - http://orbilu.uni.lu/handle/10993/36404

  • Hoffman, P., Arendt, V., Fischer, A., Menster, M., Etienne, V., Meyers, J., Conrath, M., Stein, R., Braunert, C., Foulon, M-L., & Seguin-Devaux, C. (2020). Combination disease prevention in prisons: a comprehensive programme in Luxembourg. In WHO (Eds.), Compendium of good practices in health sector response to viral hepatitis in the WHO European Region (pp. 50-53). Copenhagen: World Health Organization Regional Office for Europe.

  • Origer, A. (2017). A methodological inventory for the assessment of selected, unlabelled direct public expenditure in the field of drug demand reduction. In European Monitoring Centre for Drugs and Drug Addiction, Drug treatment expenditure: a methodological overview EMCDDA Insights 24. Luxembourg: Publications Office of the European Union. doi:10.2810/052028

  • Origer A., Le Bihan E., & Baumann, M. (2015). A Social Gradient in Fatal Opioids and Cocaine Related Overdoses?
    PLoS One., 10(5). doi: 10.1371/journal.pone.0125568.
    https://www.ncbi.nlm.nih.gov/pubmed/25938451

  • Origer A., Lopes da Costa S., & Baumann, M. (2014). Opiate and cocaine related fatal overdoses in Luxembourg from 1985 to 2011: A study on gender differences. Eur Addict Res., 20(2):87-93. doi:10.1159/000355170.
    http://www.ncbi.nlm.nih.gov/pubmed/24192492

  • Origer A., Le Bihan, E. & Baumann, M. (2014). Social and economic inequalities in fatal opiate and cocaine related overdoses in Luxembourg: A case-control study. Int. J. Drug Pol. doi: 10.1016/j.drugpo.2014.05.015.
    http://www.ncbi.nlm.nih.gov/pubmed/25002330

  • Origer A., & Schmit J.-C. (2012). Prevalence of hepatitis B and C and HIV infections among problem drug users in Luxembourg: self-report versus serological evidence. J Epidemiol Community Health, 66, 64–68. doi:10.1136/jech.2009.101378.
    http://www.ncbi.nlm.nih.gov/pubmed/20889592

  • Origer, A. (2012). Prevalence of Problem Drug Use and Injecting Drug Use in Luxembourg: A Longitudinal and Methodological Perspective. Eur Addict Res., 18:288-296. doi:10.1159/000337211.
    http://www.ncbi.nlm.nih.gov/pubmed/22854631

  • Buchicchio, L., Asselborn, L., Schneider, S. et al. (2022). Investigation of aflatoxin and ochratoxin A contamination of seized cannabis and cannabis resin samples. Mycotoxin Res, 38, 71–78. https://doi.org/10.1007/s12550-022-00449-z

  • Removille, N., Origer, A., Couffignal, S., Vaillant, M., Schmit, J-C, & Lair, ML (2011). A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations. BMC Public Health, 11(1):351.
    http://www.ncbi.nlm.nih.gov/pubmed/21595969

  • Schneider, S. & Meys, F. (2011). Analysis of illicit cocaine and heroin samples seized in Luxembourg from 2005– 2010, Forensic Sci. Int. doi:10.1016/j.forsciint.2011.06.027.
    http://www.ncbi.nlm.nih.gov/pubmed/21767923

Publications

Last update